ERHSX Mutual Fund

NAV$14.60

Fund Essentials - as of Feb 28, 2026

Net Assets
$60M
Expense Ratio
1.43%
Dividend Yield (Current)
6.45%
Holdings
44
Inception Date
Sep 8, 2003
Fund Family
Eaton Vance
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD-0.89%
1 Year+10.45%
3 Year+5.73%
5 Year+6.29%
10 Year+9.06%

Asset Allocation

Stocks: 99.97%
Other: 0.03%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co11.33%
ABBVAbbvie Inc6.66%
AZN:LNAstraZeneca PLC6.54%
JNJJohnson & Johnson6.28%
ROG:SMRoche Holding Ag5.85%
Top 10 Concentration: 55.71%Report Date: Feb 28, 2026
Download all 44 holdings for ERHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.45%
Frequency
Annually
Latest Distribution
$1.17
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

ERHSX Mutual Fund Overview

ERHSX Mutual Fund (Eaton Vance WorldWide Health Sciences Fund Class R) is managed by Eaton Vance with $60.0M in net assets. ERHSX expense ratio is 1.43%, holding 44 positions across sectors including Health Care, Unknown, Financials. Inception date: 2003-09-08.

ERHSX performance shows a YTD return of -0.89%. The 1-year return is 10.45% and the 5-year return is 6.29%. ERHSX dividend yield stands at 6.45%, paid annually.

ERHSX top holdings include Eli Lilly & Co (11.3%), Abbvie Inc (6.7%), AstraZeneca PLC (6.5%), Johnson & Johnson (6.3%), Roche Holding Ag (5.8%). View all ERHSX holdings, sector breakdown, or dividend history.

ERHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. ERHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.